AIM - AIM ImmunoTech Inc. (AIM) Q1 2024 Earnings Call Transcript
2024-05-16 11:24:09 ET
AIM ImmunoTech Inc. (AIM)
Q1 2024 Earnings Conference Call
May 16, 2024 08:30 AM ET
Company Participants
Thomas Equels - CEO
Christopher McAleer - Scientific Officer
Conference Call Participants
James Molloy - Alliance Global Partners
Ed Woo - Ascendiant Capital Markets
Presentation
Operator
Hello, and welcome to the AIM ImmunoTech First Quarter 2024 Update Conference Call and Webcast. As a brief reminder, all participants are currently in a listen-only mode. [Operator Instructions] Following the presentation, there will be a question-and-answer session. Note that this webcast is being recorded at the company's request, and a replay will be made available on the company's website following the end of the event.
At this time, I'd like to remind our listeners that remarks made during this webcast may state management's intentions, beliefs, expectations or future projections. These are forward-looking statements and involve risks and uncertainties. Forward-looking statements on this call are made pursuant to the safe harbor provisions of the federal securities laws and are based on AIM ImmunoTech's current expectations, and actual results could differ materially.
As a result, you should not place undue reliance on any forward-looking statements. Some of the factors that could cause actual results to differ materially from those contemplated by such forward-looking statements are discussed in the periodic reports AIM ImmunoTech files with the Securities and Exchange Commission. These documents are available in the Investors section of the company's website and on the Securities and Exchange Commission's website. We encourage you to review these documents carefully....
AIM ImmunoTech Inc. (AIM) Q1 2024 Earnings Call Transcript